Keyphrases
Action Potential
25%
African American
25%
Baseline Testing
25%
Body Mass Index
25%
Concentric Needle Electromyography
100%
Current Perception Threshold
75%
Cyclobenzaprine
50%
Imipramine
50%
Lower Urinary Tract Symptoms
50%
Medication Effects
100%
Medication Therapy
25%
Multi-motor
25%
Neuromuscular Function
75%
No Significant Difference
25%
Nonparametric Test
25%
Physiological Effects
25%
Placebo
50%
Postmenopausal Women
25%
Pre-post Change
25%
Pressure-flow Study
100%
Pseudoephedrine
75%
Solifenacin
50%
Stimulus Intensity
25%
Tamsulosin
50%
Threshold Flux
25%
Threshold Test
50%
Unit Action
25%
Urethral Sensation
75%
Urethral Sphincter
100%
Urodynamics
25%
Medicine and Dentistry
Action Potential
20%
Body Mass Index
20%
Cyclobenzaprine
40%
Electromyography
80%
Imipramine
40%
Lower Urinary Tract Symptom
40%
Neuromuscular Function
60%
Nonparametric Test
20%
Perceptive Threshold
60%
Placebo
40%
Premenopause
20%
Pseudoephedrine
60%
Sensation
100%
Solifenacin
20%
Solifenacin Plus Tamsulosin
20%
Sphincter
100%
Tamsulosin
20%
Urodynamics
20%
Nursing and Health Professions
Action Potential
25%
Body Mass
25%
Cyclobenzaprine
50%
Electromyography
100%
Imipramine
50%
Lower Urinary Tract Symptom
50%
Nonparametric Test
25%
Perceptive Threshold
75%
Placebo
50%
Pseudoephedrine
75%
Solifenacin
25%
Solifenacin Plus Tamsulosin
25%
Tamsulosin
25%
Neuroscience
Action Potential
25%
Body Mass Index
25%
Cyclobenzaprine
50%
Electromyography
100%
Imipramine
50%
Neuromuscular Function
75%
Placebo
50%
Pseudoephedrine
75%
Solifenacin
50%
Tamsulosin
50%